Impact Factor
4.53
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
8.46
2,494 total citations
h5-index
67
h5 depth signal
Cited share
90.3%
288 of 319
Total citations
2,494
Citation footprint
Metric signal
8.61
External metric anchor
Self-citation
0.8%
19 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
495
Germany
355
China
263
United Kingdom
245
France
212
Citing Fields of Research
Immunology
316
Cancer & Development
174
Neurodegenerative Disorders
152
Oncology
147
Cancer, Autophagy & Apoptosis
140
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
2,380
Articles tracked across the journal lifetime
Indexed publication set
319
288 cited publications
Last 12 months
206
17.2 publications/month
Open access share
100.0%
206 OA publications in the last year
Leading citing country
United States
495 citing publications
Leading citing field
Immunology
316 citing publications
Latest tracked publication
15 October 2026
10 recent records available
Coverage & Indexing History
v1n1, Apr. 2009-
v1n1, Apr. 2009-
Active Coverage
Research Focus & Classification
Indexed Subjects
Immunology
Mitochondria
Neurodegenerative Disorders
Cancer & Development
Musculoskeletal Disorders
Cancer, Autophagy & Apoptosis
Issuing & Sponsoring Bodies
Contributor
European Molecular Biology Organization
Broad Categories
Molecular Biology
Immunology
Cancer, Autophagy & Apoptosis
Musculoskeletal Disorders
Mitochondria
Cancer & Development
Neurodegenerative Disorders
Immunotherapy
MeSH Descriptors
Genetic Phenomena
Medicine
Molecular Biology
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1038/s44321-026-00533-2
Open DOI
PTEN-loss confers dependence on the guanylate synthesis enzyme IMPDH in T-cell acute lymphoblastic leukemia
Loss of the tumor suppressor PTEN is common in T-cell acute lymphoblastic leukemia (T-ALL) and is associated with poor prognosis. PTEN-loss drives AKT/mTORC1 signaling to promote leukemic cell growth. We find that PTEN-loss in T-ALL conf...
02
DOI 10.1038/s44321-026-00534-1
Open DOI
RMND1 dysfunction causes OXPHOS deficiency and alters mitoribosomal protein homeostasis in vivo
Pathogenic, bi-allelic variants in RMND1 typically manifest as an early-onset multisystemic mitochondrial disease, yet the consequences of RMND1 dysfunction in vivo remain poorly understood. To answer this question, we generated and char...
03
DOI 10.1038/s44321-026-00527-0
Open DOI
Artificial intelligence in central nervous system autoimmune diseases: from clinical decision support to mechanistic discovery and translation
Central nervous system (CNS) autoimmune diseases, including multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), autoimmune encephalitis (AE), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD...
04
DOI 10.1038/s44321-026-00513-6
Open DOI
Extracellular RNA clearance by non-canonical cell-surface MDA5 protects against lung fibrosis
The role of innate immune receptors, specifically RNA sensors, in non-pathogen-driven lung fibrosis remains unclear. Here, we demonstrate that the cytosolic RNA sensor MDA5 could translocate to the cell surface upon bleomycin-induced dam...
05
DOI 10.1038/s44321-026-00514-5
Open DOI
FAP adipogenesis drives early spinal muscle loss in dysferlinopathy and reveals a therapeutic target
Dysferlinopathy (Limb Girdle Muscular Dystrophy R2/LGMD2B) causes progressive weakness of limb-girdle muscles. Although gait abnormalities are common, the contribution of spinal muscles to disease symptoms remains poorly understood. Usin...
06
DOI 10.1038/s44321-026-00535-0
Open DOI
FDXR upregulation by p63/p73 is a prognostic and therapeutic marker of adult T-cell leukemia/lymphoma
Infection with HTLV-1 can lead to severe diseases, including adult T-cell leukemia/lymphoma (ATL), for which current therapies are inadequate. Selective elimination of chronically infected cells requires identifying cellular markers dysr...
07
DOI 10.1038/s44321-026-00539-w
Open DOI
Spatiotemporal heterologous vaccination relies on type I interferons at priming to enhance mucosal immunity
Parenteral vaccines against respiratory viruses poorly block infection and transmission due to suboptimal induction of mucosal immunity. In contrast, hybrid immunity and heterologous-route immunization regimens generate protective mucosa...
08
DOI 10.1038/s44321-026-00529-y
Open DOI
Activated protein C promotes hematopoietic stem and progenitor cell quiescence and engraftment
Hematopoietic stem cells (HSCs) are the definitive source of all blood cells and replenish them for life. The endothelial protein C receptor (EPCR) which signals via its coreceptor protease-activated receptor 1 (PAR1) is expressed on a s...
09
DOI 10.1038/s44321-026-00525-2
Open DOI
Apc-deficient pituitary stem cells drive adamantinomatous craniopharyngioma through senescence-associated inflammation
Adamantinomatous craniopharyngiomas (aCPs) are complex intracranial neoplasms that arise in the sellar and suprasellar region of the brain, affecting the endocrine and nervous systems, causing severe sequelae. Although most of aCPs are d...
10
DOI 10.1038/s44321-026-00540-3
Open DOI
A novel Torque teno virus qPCR assay reveals longitudinal viral load variability among non-immunosuppressed subjects
Torque teno virus (TTV) DNA is an emerging biomarker of the individual immune status with considerable potential for guiding immunosuppressive therapy. However, widespread clinical implementation has been hampered by the lack of standard...
Bibliographical & Catalog Notes
Description based on: 2009/1; title from cover.
Latest issue consulted: 2009/1.
Print issues ceased with v. 3, no.12 (2011).
Also issued online.